We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The current design of the IOL is characterized by ...
Pharmacotherapy is the newest modality of presbyopia management, with the first agent (pilocarpine) gaining FDA approval for presbyopia in 2021. It offers a local, non-invasive, and reversible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results